Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04182997

Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy

Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy for Herniated Lumbar Discs Is There a Role? - A Randomized Control Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine a grading system for inflammation in lumbar disc herniation and which groups, if any, benefit most from the administration of an intra-operative epidural steroid.

Detailed description

Intraoperative epidural administration of steroids following discectomy for herniated lumbar disc has been the topic of multiple studies in the literature. The results have been mixed, with the majority of the studies finding some benefit, but outcomes have varied drastically amongst the many studies. The aim of this study is to develop a grading scale for intraoperative assessment of nerve root inflammation to determine if this subjective assessment is an adequate indicator for response to epidural steroids following discectomy. Patients will be allocated randomly preoperatively to the intervention group versus control group. Pictures of the spinal cord and associated nerve root will be captured intraoperatively. These pictures will be scrutinized postoperatively and an inflammation grade will be assigned. The investigators will then identify if nerve roots with a higher-grade of inflammation respond differently to epidural steroid administration when compared to lesser-grades of inflammation. This will be measured with the a variety of outcome measures.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasonePatients included in the treatment group will have their surgical site lavaged with dexamethasone at the end of their surgery.
DRUGsaline 0.9%Patients included in the placebo group will have their surgical site lavaged with sterile saline at the end of their surgery.

Timeline

Start date
2019-11-21
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2019-12-02
Last updated
2025-05-04

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04182997. Inclusion in this directory is not an endorsement.